Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Pain in multiple sclerosis: A systematic review of neuroimaging studies.
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.
Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis.
Type I and III interferons enhance IL-10 receptor expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12p70 production.
Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
[Diffusion-tensor magnetic resonance tomography and tractography in multiple sclerosis: a review].
Serum levels of LIGHT in MS.
Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation.
Does jcv antibody positivity encourage cessation of natalizumab therapy in multiple sclerosis?
Purification and biological characterization of soluble, recombinant mouse IFNβ expressed in insect cells.
[New and emerging treatments for multiple sclerosis].
Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
[The process of meaning-making in adjustment to multiple sclerosis.]
Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent.
Natalizumab (BG00002) Re-Initiation of Dosing. (STRATA)
Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
Detecting clinically-relevant changes in progressive multiple sclerosis.
Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
Pages
« first
‹ previous
…
317
318
319
320
321
322
323
324
325
…
next ›
last »